@inproceedings{inproceedings, title  = {{Serum concentrations of AMG 162 were maintained and bone resorption was suppressed for 3 months following a single subcutaneous dose in patients with breast cancer-related bone metastases}},

 url = {{}},

 year = {{2004}},

 month = {{9}},

 author = {{Peterson MC and Martin SW and Stouch BJ and Chen D and Bauhman S and Holloway DL and Rasmussen AS and Lipton A and Coleman R and Body JJ and Bekker PJ et al}},

 volume = {{19}},

 journal = {{JOURNAL OF BONE AND MINERAL RESEARCH}},

 issue = {{9}},

 pages = {{1595-1595}},

 note = {{Accessed on 2025/10/10}}}